Unseen Danger: Peripartum Cardiomyopathy in a Preeclamptic Mother with Irregular Antenatal Care at a Secondary Hospital in Jayapura, PapuaA Case Report and Literature Review
Keywords:
Peripartum Cardiomyopati, Preeclamsia, Antenatal CareAbstract
Introduction
Peripartum cardiomyopathy (PPCM) is a form of dilated cardiomyopathy that occurs in the last month of pregnancy or within the first five months postpartum. Preeclampsia, characterized by hypertension and organ dysfunction, increases the risk of long-term maternal cardiovascular complications. Antenatal Care (ANC) has a key role in the early detection and prevention of conditions like PPCM in women with preeclampsia.
Case Illustration:
A 22-year-old primiparous woman presented with severe difficulty breathing, fatigue, and leg swelling. She had given birth 35 days earlier who had prior episodes of preeclampsia and intrauterine growth restriction (IUGR). Examination revealed lung crackles, murmur, a gallop heart rhythm, and pitting edema. ECG showed sinus tachycardia and right ventricular enlargement, while chest X-ray indicated cardiomegaly with pulmonary edema. Treatment consisted of diuretics, beta-blockers, fluid restriction, and ICU care. During her last pregnancy, she had experienced leg swelling since 37 weeks gestation but had irregular ANC visits, no obstetric ultrasound, and only took vitamins from a primary healthcare center.
Discussion:
This case highlights the association between preeclampsia and PPCM, a severe Peripartum cardiovascular complication. The patient exhibited classic PPCM symptoms, including shortness of breath, fatigue, and leg edema, with clear signs of cardiac dysfunction. A key factor was poor pregnancy monitoring, as she did not attend ANC regularly, leading to undiagnosed preeclampsia and its complications.
Conclusion:
PPCM is a serious cardiovascular complication related to preeclampsia. Regular ANC, including ultrasound screening and blood pressure monitoring, is essential to early detection and prevention of adverse maternal and fetal outcomes.
References
Okeke TC, Ezenyeaku CCT, Ikeako LC. Peripartum Cardiomyopathy. Ann Med Health Sci Res. 2013;3(3):313–9.
Sliwa K, Petrie MC, Hilfiker‐Kleiner D, Mebazaa A, Jackson A, Johnson MR, et al. Long‐term Prognosis, Subsequent Pregnancy, Contraception and Overall Management of Peripartum Cardiomyopathy: Practical Guidance Paper from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy. Eur J Heart Fail. 2018;20(6):951–62.
Pearson GD, Veille JC, Rahimtoola S, Hsia J, Oakley CM, Hosenpud JD, et al. Peripartum Cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) Workshop Recommendations and Review. JAMA. 2000;283(9):1183–8.
Polskie Towarzystwo Kardiologiczne. Guidelines of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH) [Internet]. 2018 [cited 2022 Apr 20]. Available from: https://ptkardio.pl/wytyczne/1-wytyczne_escesh_dotyczace_postepowania_w_nadcisnieniu_tetniczym
Isezuo SA, Abubakar SA. Epidemiologic Profile of Peripartum Cardiomyopathy in a Tertiary Care Hospital. Ethn Dis. 2007;17(2):228–33.
Fett JD, Christie LG, Carraway RD, Murphy JG. Five-year Prospective Study of The Incidence and Prognosis of Peripartum Cardiomyopathy at a Single Institution. In: Mayo Clinic Proceedings. Elsevier; 2005. p. 1602–6.
Kamiya CA, Kitakaze M, Ishibashi-Ueda H, Nakatani S, Murohara T, Tomoike H, et al. Different Characteristics of Peripartum Cardiomyopathy Between Patients Complicated with and Without Hypertensive Disorders Results from the Japanese Nationwide Survey of Peripartum Cardiomyopathy. Circulation Journal. 2011;75(8):1975–81.
Prameswari HS, Purnomowati A, Aprami TM. Prevalence, Characteristics, and Risk Factor of Patient with Peripartum Cardiomyopathyin Hasan Sadikin Hospital Bandung. Indonesian Journal of Cardiology. 2015;38–44.
Behrens I, Basit S, Lykke JA, Ranthe MF, Wohlfahrt J, Bundgaard H, et al. Hypertensive Disorders of Pregnancy and Peripartum Cardiomyopathy: A Nationwide Cohort Study. PLoS One. 2019;14(2).
Bello N, Rendon ISH, Arany Z. The Relationship Between Pre-eclampsia and Peripartum Cardiomyopathy: A Systematic Review and Meta-Analysis. J Am Coll Cardiol. 2013;62(18):1715–23.
Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd-Jones DM, et al. Effectiveness Based Guidelines for the Prevention of Cardiovascular Disease in Women 2011 Update: A Guideline from the American Heart Association. J Am Coll Cardiol. 2011;57(12):1404–23.
Melchiorre K, Sutherland GR, Liberati M, Thilaganathan B. Preeclampsia is Associated with Persistent Peripartum Cardiovascular Impairment. Hypertension. 2011;58(4):709–15.
Ersboll AS, Bojer AS, Hauge MG, Johansen M, Damm P, Gustafsson F, et al. Long‐term Cardiac Function After Peripartum Cardiomyopathy and Preeclampsia: A Danish Nationwide, Clinical Follow‐up Study Using Maximal Exercise Testing and Cardiac Magnetic Resonance Imaging. J Am Heart Assoc. 2018;7(20).
Griffin BP, Topol EJ, Nair D, Ashley K. Manual of Cardiovascular Medicine. Lippincott Williams & Wilkins; 2008.
Mann DL. Pathophysiology of Heart Failure. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. 2012;487–504.
Abboud J, Murad Y, Chen-Scarabelli C, Saravolatz L, Scarabelli TM. Peripartum Cardiomyopathy: A Comprehensive Review. Int J Cardiol. 2007;118(3):295–303.
Phanaka EL, Iqbal M, Wiwaha G. Case Study on Cardiac Decompensation in Patients with Preeclampsia and Peripartum Cardiomyopathy. Majalah Kedokteran Bandung. 2020;52(1):53–60.
Bauersachs J, König T, van der Meer P, Petrie MC, Hilfiker‐Kleiner D, Mbakwem A, et al. Pathophysiology, Diagnosis and Management of Peripartum Cardiomyopathy: A Position Statement from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy. Eur J Heart Fail. 2019;21(7):827–43.
Kara M, Orbak Z, Döneray H, Ozkan B, Akcay F. The Relationship Between Skinfold Thickness and Leptin, Ghrelin, Adiponectin, and Resistin Levels in Infants of Diabetic Mothers. Fetal Pediatr Pathol. 2017 Jan 2;36(1):1–7.
Anchang-Kimbi JK, Achidi EA, Apinjoh TO, Mugri RN, Chi HF, Tata RB, et al. Antenatal Care Visit Attendance, Intermittent Preventive Treatment During Pregnancy (IPTp) and Malaria Parasitaemia at Delivery. Malar J. 2014;13:1–9.
Mmbaga BT, Lie RT, Olomi R, Mahande MJ, Olola O, Daltveit AK. Causes of Perinatal Death at A Tertiary Care Hospital in Northern Tanzania 2000–2010: A Registry Based Study. BMC Pregnancy Childbirth. 2012;12:1–9.
Zeng SQ. Risk Assessment and Holistic Nursing on High-risk Pregnant Women During Prenatal Period. Nursing Practice and Study. 2010;7(10):52–4.
Tandu-Umba B, Mbangama MA, Kamongola KMB, Kamgang Tchawou AG, Kivuidi MP, Kasonga Munene S, et al. Pre-pregnancy High-risk Factors at First Antenatal Visit: How Predictive are These of Pregnancy Outcomes? Int J Womens Health. 2014;1011–8.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Theresia Herestuwito Naru, Kadek Yunior K, Henny Rumaropen (Author)

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors publishing here keep copyright but grant the journal first publication rights, under a Creative Commons Attribution-NonCommercial 4.0 License. They can distribute their work non-exclusively elsewhere with an acknowledgment of its first publication in this journal. Posting the work online before and during submission for earlier and greater citation is encouraged, reflecting Open Access benefits.
